Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.

Saved in:
Bibliographic Details
Title: Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant.
Authors: Ariza-Heredia, Ella J1 (AUTHOR) rfchemaly@mdanderson.org, Winston, Drew J2 (AUTHOR), Rowley, Scott D3 (AUTHOR), Mullane, Kathleen4 (AUTHOR), Chandrasekar, Pranatharthi5 (AUTHOR), Hari, Parameswaran6 (AUTHOR), Avery, Robin K7 (AUTHOR), Peggs, Karl S8 (AUTHOR), Kumar, Deepali9 (AUTHOR), Nath, Rajneesh10 (AUTHOR), Ljungman, Per11 (AUTHOR), Mossad, Sherif B12 (AUTHOR), Haddad, Lynn El13 (AUTHOR), Shah, Dimpy P14 (AUTHOR), Jiang, Ying1 (AUTHOR), Khawaja, Fareed1 (AUTHOR), Dadwal, Sanjeet15 (AUTHOR), Blanchard, Ted16 (AUTHOR), Chemaly, Roy F1 (AUTHOR) rfchemaly@mdanderson.org
Source: Open Forum Infectious Diseases. Aug2023, Vol. 10 Issue 8, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23288957
DOI:10.1093/ofid/ofad386